1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
about
Vitamin D metabolism and action in human bone marrow stromal cellsEffects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal womenTreatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture.Cellular actions of insulin-like growth factor binding proteins.Vitamin D and bone.Interactions between vitamin D and IGF-I: from physiology to clinical practice.Structure-function analysis of the human insulin-like growth factor binding protein-4.Research resource: whole transcriptome RNA sequencing detects multiple 1α,25-dihydroxyvitamin D(3)-sensitive metabolic pathways in developing zebrafish.Vitamin D and gene networks in human osteoblasts.Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies.Skeletal effects of growth hormone and insulin-like growth factor-I therapy.Rationale for active vitamin D analog therapy in senile osteoporosis.Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls.Spaceflight modulates insulin-like growth factor binding proteins and glucocorticoid receptor in osteoblasts.Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle.Role of IGF-I and Efn-Eph Signaling in Skeletal Metabolism.Lactoferrin promote primary rat osteoblast proliferation and differentiation via up-regulation of insulin-like growth factor-1 expression
P2860
Q24649058-C28B4EDE-1596-4F6E-AE44-9AC67B1FFC5EQ28373650-E59B000F-9F52-4F8A-B869-1F7D044FCB47Q31909441-49635772-F732-44B8-BB10-7A1F79091502Q33607372-7FA145B9-1700-40A6-BAC2-6277773E280FQ34250790-9ED1D26D-1C8D-4479-99CD-50544052B490Q34352477-16DB3AE7-D977-4EAD-9204-94401D2A806EQ34751766-C55B3BF6-6530-44BC-A1A5-44AA1C7AAA5AQ36210990-158C22F6-87C4-4DE3-9A44-F44D384C1520Q38208297-78CD4A87-4521-4A3E-AA23-99B5E7639B6DQ38781328-FB16010E-76CB-46DA-93E8-2346B809C110Q39527508-52A2DDDD-B208-4EE3-83FB-C9FFB5940B98Q46601219-EE0DEE02-0431-4503-BBB1-C58BF75982BEQ46739990-85E1E0B3-0918-40AA-9EDA-AFED650267F2Q47875941-D9C0DD2C-16B9-4171-B9BE-A07DFFBB80C3Q50336343-B088CEEA-13DA-4B5A-889F-703C2B80ECDEQ52341096-2E6333CB-40D1-4BC8-9794-A8CD055CD813Q56516677-81C78E46-9033-4B70-9164-05519EE34C28
P2860
1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
1,25-Dihydroxyvitamin D3 diffe ...... rotein-4 in mouse osteoblasts.
@en
type
label
1,25-Dihydroxyvitamin D3 diffe ...... rotein-4 in mouse osteoblasts.
@en
prefLabel
1,25-Dihydroxyvitamin D3 diffe ...... rotein-4 in mouse osteoblasts.
@en
P2093
P356
P1433
P1476
1,25-Dihydroxyvitamin D3 diffe ...... rotein-4 in mouse osteoblasts.
@en
P2093
P304
P356
10.1210/ENDO-129-6-3139
P407
P577
1991-12-01T00:00:00Z